Bioinformatix' Rx&You: Enterprise Intelligence for Medications
-
Upload
bioinformatix-llc -
Category
Healthcare
-
view
1.974 -
download
1
Transcript of Bioinformatix' Rx&You: Enterprise Intelligence for Medications
Enterprise & Predictive Intelligence for MedicationsRx&YouTM
The Prospect of Delivering Billions in Value
ERIC LUELLEN | STEVE HELMS | JEFFREY WEISS | ED CUMMINGS
Purpose & Meaning
201511 Multi Billion $
Prospects Interested
We are on a mission to revolutionize healthcare delivery by learning which medications work best for which patients, maximizing clinical outcomes
and medication safety while dramatically reducing the cost of healthcare, thereby saving millions of lives and billions of dollars per year.
Based in Boston Team of 6Started in 2015 Social Proof
Medication non-
adherenceAdverse drug
eventsMany
disconnected doctors
Which drugs for whom &
when?
Problems of Global Scale
1 billion cases per year 75 million US patients don’t take their medications properly; rest-of-world is worse.
Inefficient Market = Millions of lives and billions of dollars lost every year
1.5 million US AE/year8% of patients have serious & costly events; 300K seniors & 180K are fatal.
Disorganized teamsUS adults see 18-28 docs in life with little coordination of what each are doing.=
Pharmacogenomics -Personalized medicine416 million drug combos for 7 billion people; few know which works for whom
Market Size
$535 billion per year
$21 billion per year
Total Available MarketPreventable medical expenses from medication non-adherence (MNA) & adverse events (AE).
Serviceable Available MarketMaximum improvement possible in preventing medical expenses from MNA & AE.
Serviceable Obtainable MarketMinimum improvement possible in preventing medical expenses from MNA & AE.
Providers receive team-wide reports and real-
time alerts from platform’s AI rules and predictive analytics.
Providers prioritize risks & intervene, preventing
expensive medical consequences by getting
the right info at right times.
Our cloud platform ingests and collects
streams of patient data, and transforms it into
meaning and acts.
Solution
Patients receive alerts & education how they
prefer, when & how to take their medications, tracking behavior and
side effects.
Our Product30 National Health ServicesEst. $100 billion/year of preventable medical expenses from med non-adherence and adverse events.
20 Major Heath InsurersEst. $114 billion/year of preventable medical expenses from med non-adherence and adverse events.
1 billion cases per year 75 million US patients don’t take their medications properly; rest-of-world is worse.
Creates sustainable growthBy winning the race to biggest-best data fastest, we can win the race to infonomics and personalized medicine.
We are inventing the future of medication healthcare.By combining five technologies of the future we can learn and rank the effectiveness of every medication for every patient while maximizing care quality and dramatically reducing its cost simultaneously.
Testimonials
“An immense need and consequent opportunity.”
“It’s interesting; it has the marks of a good idea. I think you’re onto something.”
“A very promising solution to one of the Holy Grails of modern medicine.”
“AI and CEP to develop a drug- event system that screens for drug interactions in real time and alerts, etc. is innovative. “
Robert Herjavec, CEO, The Herjavec Group,
Star of “Shark Tank”
Dr. Eric Isselbacher, Director, Healthcare Transformation Lab,
Mass. Gen. Hospital
Dr. David Luckham, Professor,Stanford University
(Emeritus)
Chris Coburn,Chief Innovation Officer,
Partners Healthcare
Why Now?
“I think the biggest
innovations of the 21st century will
be the intersection of
biology and technology; a new era is beginning.”
Steve Jobs
Business Model
B2B2C PatientsPayers, providers, or pharmas add patients in large cohorts from one sale or license.
Patient SavingsAn est. $5,000 per patient per year in prevented medical expenses.
75M $5,000Subscription Model75M x $5K /year x 10% = a $37.5B sustainable company BEFORE going international.
$37.5Bx =
We take a 10% fee of savings of preventable medical expenses.
Value-based PricingWe keep 10% of money saved from preventable medical events.
10%x
Medication Adherence
Pharmaco-genomics
(PM)
BPaaS
IoT AI
Pharmaco-kinetics
(PK)
Competitive Landscape
Rx&YouTM
Competitive Advantages
First to MarketFor AI & IoT across all medication delivery in real-time – an 18-24 month market lead
Best-of-Breed28 best intervention
approaches – dozens more than competitors – layered to maximize care and value
Personalized MedicineAbility to add patients’
genomic variants means owning the knowledge to match meds to patients
Coordinates CareDocs & pharma, for the first time, can see across systems
to know and coordinate patient treatment.
Killer TeamSteve Helms, Co-founder & CTO• Led development for 18 months• Serial technology entrepreneur• 20 years software development experience• BBA from Texas A&M
Jeffrey Weiss, Chief Operating Officer• 20 years global management experience• Former White House advance leader• Advised dozens of sovereign states &
Fortune 500 companies
Ed Cummings, Chief Marketing Officer• Product manager @ Microsoft for 12 years• Led $30B IP acquisition @ Microsoft• JD from University of Minnesota
AdvisorsAmy Odom, Advisor• Health insurance executive for 19 years• Partner @ Denton’s – World’s largest
polycentric law firm – in healthcare• Represents national payers
Samantha Surrey, Advisor• Works with MD Anderson on the Moonshot • Former M&A executive – GSK• 16 years in pharma and med device innovation• Sold 3D protein-folding venture to Microsoft• MSE from University of Penn, BS from Cornell
Eric Luellen, Co-founder & CEO• Former CTO medical software company• 20 years experience leading IT solutions to
Fortune 500 companies as entrepreneur• MS in health informatics @ Northwestern
Milestones
The IdeaSeptember 2015Founders have new idea to improve medication adherence.
First DemoFebruary 2016The first demo of RX&You™ given at Massachusetts General Hospital.
Provisional PatentApril 2016RX&You™ patents filed at US Patent Office advised by Fenwick & West.
C3 Prize FinalistSeptember 2016RX&You™ chosen as a top 5 finalist & audience favorite at Stanford MedX.
Found by PressSeptember 2016Eligible says RX&You™ 1 of 7 healthcare start-ups you should know.
World Tech FinalistNovember 2016RX&You™ chosen as 1 of 6 global finalists for WTN Award in health and medicine.